Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
This report contains market size and forecasts of Hemoperfusion Production in global, including the following market information:
Global Hemoperfusion Production Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemoperfusion Production Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemoperfusion Production companies in 2021 (%)
The global Hemoperfusion Production market was valued at 590.6 million in 2021 and is projected to reach US$ 1546.2 million by 2028, at a CAGR of 14.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Resin Adsorption Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemoperfusion Production include Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Asahi-Kasei, Kaneka, Zibo Kangbei, Aier and Cytosorbents. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemoperfusion Production manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoperfusion Production Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemoperfusion Production Market Segment Percentages, by Type, 2021 (%)
Resin Adsorption
Activated Carbon Adsorption
Others
Global Hemoperfusion Production Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemoperfusion Production Market Segment Percentages, by Application, 2021 (%)
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
Global Hemoperfusion Production Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemoperfusion Production Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoperfusion Production revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemoperfusion Production revenues share in global market, 2021 (%)
Key companies Hemoperfusion Production sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemoperfusion Production sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents